Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Ali

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Addiction (Abingdon, England)|February 27, 2023
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17Sarah Larney, Nicola R Jones, Matthew Hickman, et al.
Addiction (Abingdon, England)|January 8, 2019
Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?John Marsden, Betty Tai, Robert Ali, et al.
Drug and Alcohol Review|May 8, 2015
The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulationsBriony Larance, Paul Dietze, Robert Ali, et al.
Drug and Alcohol Dependence|December 14, 2005
One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)Maree Teesson, Joanne Ross, Shane Darke, et al.
Drug and Alcohol Review|November 22, 2005
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS)Joanne Ross, Maree Teesson, Shane Darke, et al.
Addiction (Abingdon, England)|July 14, 2019
Response to commentariesJohn Marsden, Betty Tai, Robert Ali, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 4, 2017
Feasibility of Studying a Brief Intervention to Help Chinese Villagers with Problem Alcohol Use After an EarthquakeRuan Xiaolu, Wang Wenwen, Robert Ali, et al.
Addiction (Abingdon, England)|March 26, 2003
Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patientsRichard P Mattick, Robert Ali, Jason M White, et al.
Drug and Alcohol Dependence|September 6, 2003
Buprenorphine versus methadone maintenance: a cost-effectiveness analysisChristopher M Doran, Marian Shanahan, Richard P Mattick, et al.
Pharmacoepidemiology and Drug Safety|October 1, 2015
A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodoneAmy Peacock, Louisa Degenhardt, Briony Larance, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Addiction (Abingdon, England)|February 27, 2023
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17Sarah Larney, Nicola R Jones, Matthew Hickman, et al.
Addiction (Abingdon, England)|January 8, 2019
Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?John Marsden, Betty Tai, Robert Ali, et al.
Drug and Alcohol Review|May 8, 2015
The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulationsBriony Larance, Paul Dietze, Robert Ali, et al.
Drug and Alcohol Dependence|December 14, 2005
One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)Maree Teesson, Joanne Ross, Shane Darke, et al.
Drug and Alcohol Review|November 22, 2005
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS)Joanne Ross, Maree Teesson, Shane Darke, et al.
Addiction (Abingdon, England)|July 14, 2019
Response to commentariesJohn Marsden, Betty Tai, Robert Ali, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 4, 2017
Feasibility of Studying a Brief Intervention to Help Chinese Villagers with Problem Alcohol Use After an EarthquakeRuan Xiaolu, Wang Wenwen, Robert Ali, et al.
Addiction (Abingdon, England)|March 26, 2003
Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patientsRichard P Mattick, Robert Ali, Jason M White, et al.
Drug and Alcohol Dependence|September 6, 2003
Buprenorphine versus methadone maintenance: a cost-effectiveness analysisChristopher M Doran, Marian Shanahan, Richard P Mattick, et al.
Pharmacoepidemiology and Drug Safety|October 1, 2015
A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodoneAmy Peacock, Louisa Degenhardt, Briony Larance, et al.
Pageof 12